医学論文（英文、1979〜1999）
1. Running and laughing fits as the sequelae of the neonatal hyperviscosity syndrome.　
Sugimoto T, Matsumura T, Sakamoto Y, Taniuchi K. Brain and Development. 1: 323~326,
1979

2. Intracranial hemorrhage following administration of sodium bicarbonate in rabbits.
Sugimoto T, Yasuhara A, Matsumura T. Brain and Development. 3:297~303, 1981

3. Hyperammonemia and orotic acid excretion following administration of valproate.
Sugimoto T, Matsumura T, Sakane Y. Acta Paediatrica Japonica. 24:336~338, 1982

4. Effects of hyperosmolality on the central nervous system and intracranial hemorrhage
Yasuhara A, Sugimoto T, Naito H, Yasuhara M, Matsumura T. Brain and Development.
4: 353~360, 1982

5. Reye-like syndrome associated with valproic acid. Sugimoto T, Nishida N, Yasuhara A, Ono A
Brain and Development. 5: 334~337, 1983

6. Early diagnosis of herpes simplex virus encephalitis in childhood by the enzyme-linked
immunosorbent assay. Sugimoto T, Sakane Y, Kobayashi Y. Acta Neurologica Scandinavica.
71:359~363, 1985

7. Computed tomography in young children with herpes simplex virus encephalitis.
Sugimoto T, Woo M, Okazaki H, Nishida N, Hara T, Yasuhara A, Kobayashi Y.
Pediatric Radiology 15:372~376, 1985

8. Ketone body and carnitine metabolism in epileptic patients with valproate (short report).
Sugimoto T, Nishida N, Woo M, Yasuhara A, Kobayashi Y, Sakane Y, Taniuchi T.
Japanese Journal of Psychiatry and Neurology. 40:443~444, 1986

9. Hopantenate-induced Reye-like syndrome. An experimental model.
Sugimoto T, Woo M, Nishida N, Takeuchi T, Sakane Y, Kobayashi Y. Acta Paediatrica
Japonica. 28: 663~669, 1986

10.Serum and urinary carnitine and organic acids in Reye syndrome. Sugimoto T, Nishida N,
Woo M, Takeuchi T, Yasuhara A, Kobayashi Y, Sakane Y. Brain and Development.
8:257~261, 1986

11. Ring chromosome 21 and SOD activity of blood cells. Aoki T , Yoshimitsu K, Itodagawa M ,
Okazaki H,Sugimoto T, Kobayashi Y. Acta Paediatrica Scandinavica. 75:1055~1058, 1986

12. Neurological outcome in full-term infants with intraventricular hemorrhage. Sugimoto T,
Woo M, Okazaki H, Sonoda N, Ono A, Kinoshita Y, Matsusaki S, Iwase S, Kobayashi Y.
Acta Paediatrica Japonica. 29: 749~752, 1987

13.Hepatotoxicity in rat following administration of valproic acid. Sugimoto T, Woo M,
Nishida N, Takeuchi T, Sakane Y, Kobayashi Y. Epilepsia. 28:142~146, 1987

14. Hepatotoxicity in rat following administration of valproic acid: effect of L-carnitine
supplementation. Sugimoto T, Araki A, Nishida N, Sakane Y, Woo M, Takeuchi T,
　　　Kobayashi Y　 Epilepsia. 28: 373~377, 1987

15. Carnitine metabolism in valproate-treated rats: the effect of D,L-carnitine supplementation 　　
　　(short report). Sugimoto T, Nishida N, Takeuchi T, Woo M, Araki A, Yasuhara A, Kobayashi Y,
Sakane Y. Japanese Journal of Psychiatry and Neurology. 41: 585~586, 1987

16. Longitudinal determination of cerebral flow verocity in neonates with the Doppler technique.
Shutou H, Yasuhara A, Nakamura M, Sugimoto T, Iwase S, Kobayashi Y. Neuropediatrics.
18: 218~227, 1987

17. Diagnostic/prognostic significance of photo-evoked eyelid microvibration in neonates with
intracranial hemorrhage. Yasuhara A, Hori A, Sugimoto T, Iwase S, Kobayashi Y.
Electroencephalography and Clinical Neurophysiology. 67:584~587, 1987

18. Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation
Nishida N, Sugimoto T, Araki A, Woo M, Sakane Y, Kobayashi Y. Pediatric Research.
22: 500~503, 1987

19. Protective effect of D,L-carnitine on valproate-induced hyperammonemia and hypoketonemia
　　inprimary cultured rat hepatocytes. Takeuchi T, Nishida N, Sugimoto T, Kobayashi Y.
Biochemical Pharmacology. 37: 2255~2258, 1988

20. Evaluation of the cytotoxicity of sodium valproate on primary cultured rat hepatocytes
Takeuchi T, Sugimoto T, Nishida N, Kobayashi Y. Neuropediatrics. 19:158~161, 1988

21. Electrophysiologic study of Fisher syndrome. Unishi G, Yasuhara A, Hori A, Sugimoto T,
Kobayashi Y. Pediatric Neurology. 4: 296~300, 1988

22. Efficacy of zonisamide in children with refractory partial seizures. Shuto H, Sugimoto T ,
Yasuhara A, Hatanaka T, Woo M, Murakami K, Araki A, Kobayashi Y. Current Therapeutic
Research. 45: 1031~1036, 1989

23. Electroencephalographic changes during interferon therapy in a case of subacute sclerosin
panencephalitis. Hatanaka T、Sugimoto T, Kobayashi Y. European Neurology. 29:6~9, 1989

24. Effect of L-carnitine on glycogen synthesis and ATP production in cultured hepatocytes of the
newborn rat. Nishida N, Sugimoto T, Takeuchi T, Kobayashi Y. Journal of Nutirition.
119:1705~1708, 1989

25. Valproate-induced hepatotoxicity : protective effect of L-carnitine supplementation　(short
report. Sugimoto T, Nishida N, Murakami K, Woo M , Sakane Y, Yasuhara A, Shuto H,
Hatanaka T, Kobayashi Y. Japanese Journal of Psychiatry and Neurology. 44:387~388,1990

26. The effect of L-carnitine supplementation in 4 pentenoic acid treated rats. Sugimoto T, Woo M,
Nishida N, Araki A. Brain and Development. 12: 417~422, 1990

27. Carnitine metabolism and morphometric change of liver mitochondria in valproate-treated rats
Murakami K, Sugimoto T, Nishida N, Woo M, Araki A, Kobayashi Y, Sakane Y.
Neuropediatrics. 21: 187~190, 1990

28. Photo-evoked eyelid microvibration in neonates with hyperosmolality. Yasuhara A, Hori A,
Sugimoto T, Kobayashi Y. Journal of Child Neurology. 5: 191~195, 1990

29. Lesch-Nyhan syndrome with delayed onset of self-mutilation: hyperactivity of interneurons at
the brainstem and blink reflex. Hatanaka T, Higashino H, Woo M, Yasuhara A, Sugimoto T,
Kobayashi Y. Acta Neurologica Scandinavica. 81: 184~187, 1990

30. Caroli's disease: scintigraphic and radiographic findings. Nishida N, Takemoto T, Yamamoto C, Sugimoto T, Kuge M. Acta Paediatrica Japonica. 33: 714~717, 1991

31. DNA deletion and its parental origin in Angelman syndrome patients. Hamabe J, Kuroki Y,
Imaizumi K, Sugimoto T, Fukusima Y, Yamaguchi A, Izumikawa Y, Niikawa N.
American Journal of Medical Genetics. 41: 64~68, 1991

32. Prediction of the prognosis in neonatal asphyxia by photo-evoked eyelid microvibration.
Yasuhara Y, Hori A, Hatanaka T, Yoshida H, Sugimoto T, Kobayashi Y.
Brain and Development.13: 82~86, 1991

33. Epilepsy with continuous spike-waves during slow sleep and its treatment. Yasuhara A,
Yoshida H, Hatanaka T, Sugimoto T, Kobayashi Y, Dyken E. Epilepsia. 32: 59~62, 1991

34. Angelman syndrome in three siblings: characteristic epileptic seizures and EEG abnormalities.
Sugimoto T, Yasuhara A, Ohta T, Nishida N, Saitoh S, Hamabe J, Niikawa N. Epilepsia. 33:
1078~1082, 1992

35. Alterations of urinary acetylcarnitine in valproate-treated rats: The effect of L-carnitine
supplementation. Murakami K, Sugimoto T, Nishida N, Woo M, Araki A, Kobayashi Y.
Journal of Child Neurology. 7: 404~407, 1992

36. Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during
chronic valproate therapy. Murakami K, Sugimoto T, Nishida N, Kobayashi Y, Kuhara T,
Matsumoto I. Brain and Development. 14: 178~181, 1992

37. Familial Angelman syndrome caused by imprinted submicroscopic deletion encompassing
GABAA receptor β３-subunit gene (Letter to editor). Saitoh S, Kubota T, Ohta T, Jinno Y,
Niikawa N, Sugimoto T, Wagstaff J, Lalande M. Lancet. 339:366~367, 1992

38. MRI of the head in the evaluation of microcephaly. Sugimoto T, Yasuhara A, Nishida N,
Murakami K, Woo M, Kobayashi Y. Neuropediatrics. 24:4~7, 1993

39. Valproate retard granule: efficacy and side effect (short report). Woo M, Sugimoto T, Nishida N,
Sasaki T, Murakami K, Yasuhara A, Araki A, Kobayashi Y. Japanese Journal of Psychiatry and
Neurology. 47: 288~290, 1993

40. Angelman syndrome in three siblings: genetic model of epilepsy associated with chromosomal
DNA deletion of the GABAA receptor (short report). Sugimoto T, Araki A, Yasuhara A, Woo
M, Nishida N, Sasaki T. Japanese Journal of Psychiatry and Neurology. 48: 271~273, 1994

41. Molecular and clinical study of 61 Angelman syndrome patients. Saitoh S, Harada N, Jinnno
Y, Hashimoto K, Imaizumi K, Kuroki Y, Fukushima Y, Sugimoto T, Renedo M, Wagstaff J,
Lalande M. American Journal of Medical Genetics. 52: 158~163, 1994

42. Prospective study of benign childhood epilepsy with centrotemporal spikes: preliminary study 　
(short report). Yasuhara A, Mastuoka O, Tamai H, Suzuki Y, Imai K, Woo M, Hattori H,
Mimaki T, Nagai T, Sugimoto T, Murata R. Japanese Journal of Psychiatry and Neurology.
48: 271~273, 1994

43. When do brain abnormalities in cerebral palsy occur ? An MRI study. Sugimoto T, Woo M,
Nishida N, Araki A, Hara T, Yasuhara A, Kobayashi Y, Yamanouchi Y. Developmental
Medicine and Child Neurology. 37: 285~292, 1995

44. Determination of urinary valproylcarnitine by gas chromatography-mass spectrometry with
selected-ion monitoring. Muro H, Tatsuhara T, Sugimoto T, Woo M, Nishida N, Murakami K,
Yamaguchi Y. Journal of Chromatography B:　Biomedical Application. 663: 83~89, 1995

45. The effect of L-carnitine supplementation on acute valproate intoxication. Murakami K,
Sugimoto T, Woo M, Nishida N, Muro H. Epilepsia. 37：687〜689、1996

46. Metabolic profiles in patients on high dose valproate monotherapy. Sugimoto T, Muro H,
Woo M, Nishida N, Murakami K. Epilepsy Research. 25 : 107~112, 1996

47.Valproate metabolites in high-dose valproate plus phenytoin therapy. Sugimoto T, Muro H,
Woo M, Nishida N, Murakami K. Epilepsia. 37:1200~1203, 1996

48. EEG spike foci in the three siblings with Angelman syndrome analysed by the tracing method.
Araki A, Sugimoto T, Yasuhara A, Kobayashi Y. Journal of Brain Science. 23:283~292, 1997

49. Outcome of epilepsy surgery in the first three years of life. Sugimoto T, Otsuba H, Hwang PA,
Hoffman HJ, Jay V, Snead OCIII. Epilepsia. 40:560~565, 1999

50. Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease.
Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M, Yamada K, Kondo S, Ikegawa S,
Nishimura G, Fukushima Y, Nakagomi T, Saito H, Sugimoto T, Kamegaya M, Hisa K, Murray JC,
Taniguchi N, Niikawa N, Yishimura K. Nature Genetics. 26:19~20, 2000

51. Acquired subglottic stenosis caused by methicillin resistant Staphylococcus aureus that
produce epidermal cell differentiation inhibitor. Yamada Y, Sugai M, Woo M, Nishida N, Sugimoto T. Arch Dis Child Fetal Neonatal Ed. 84:F38-39,2001

52.Effect of L-carnitine treatment for valproate-induced hepatotoxicity. BohanTP,Helton E,McDonald I, Konig S, Gazitt S, Sugimoto T et al. Neurology 56:1405-1409, 2001

53.Haploinsufficiency of NSD1 causes Sotos syndrome. N.Kurotaki, K.Imaizumi, N.Harada, M.Masuno, T. Kondoh, T.Nagai, H.Ohashi, K.Naritomi, M.Tsukahara, Y.Makita, T. Sugimoto, T.Sonoda, T.Hasegawa, Y.Chinen, H.Tomita, A.Kinoshita, T.Mizuguchi, K.Yoshiura, T.Ohta, T.Kishino, Y.Fukushima, N.Niikawa, N.Matsumoto.Nature Genetics 30：365-366,2002

54.Sotos syndrome and haploinsufficiency of NSD 1:clinical features of mutations and submicroscopic deletions.Nagai T, Mtsumoto N, Kurotaki N, Harada N, Niikawa N, Ogata T, Imaizumi K, Kurosawa K, Kondouh T, Ohashi H, Tsukahara M, Makita Y, Sugimoto T , Sonoda T, YokoyamaT, Uetake K, Sakazumi S, Fukushima Y, Naritomi K. J Med Genetics 40:285-289,2003